Organization | Neopharma

Neopharma Report issue

For profit Phase 2

Founded: Industrial City of Abu Dhabi United Arab Emirates (2003)

Organization Overview

First Clinical Trial

2019

NCT04020653

First Marketed Drug

2003

amoxicillin

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

NEOPHARMA | Neopharma Japan Co., Ltd.

Active Ingredients

Marketed Drugs (9)

alendronic acid (fosamax) (2008)

amoxicillin (1979)

anastrozole (arimidex) (2010)

clavulanate (Augmentin) (1984)

irbesartan (avapro) (2012)

irinotecan (Camptosar) (2010)

levocetirizine (xyzal) (2016)

pioglitazone (actos) (2013)

procaine benzylpenicillin (novocaine) (1979)

Drugs in Phase 2 Trials (3)

aminolevulinic acid (levulan) (1 trial)

artemisinin (1 trial)

ferrous citrate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 1
# of Trial APIs: 3